Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.

Dibba, Pratima; Li, Andrew A; Cholankeril, George; Ali Khan, Muhammad; Kim, Donghee; Ahmed, Aijaz

Dibba, Pratima; Li, Andrew A; Cholankeril, George; Ali Khan, Muhammad; Kim, Donghee; Ahmed, Aijaz.

Afiliación

Dibba P; Division of Gastroenterology, Women & Infants Hospital/Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Li AA; Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.
Cholankeril G; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA.
Ali Khan M; Division of Gastroenterology and Hepatology, The University of Tennessee Health Science Center, Memphis, TN, USA.
Kim D; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA.
Ahmed A; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA.

Nutr Metab Insights ; 12: 1178638819847480, 2019.

Article en En | MEDLINE | ID: mdl-31308686

Palabras clave

NAFLD; NASH; cannabinoids; cannabis; endocannabinoid; endocannabinoid system; exocannabinoid; marijuana; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Nutr Metab Insights Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google